Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Autogenous Platelet Concentrates (APCs) in Post-extraction Early Wound Healing of High-risk Medication Related Osteonecrosis of the Jaw (MRONJ) Patients.

NCT07673848 is registered in ClinicalTrials.gov with Queen Mary University of London as lead sponsor.

NCT NCT07673848
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07673848 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Autogenous Platelet Concentrates (APCs) in Post-extraction Early Wound Healing of High-risk Medication Related Osteonecrosis of the Jaw (MRONJ) Patients.
Lead sponsor
Queen Mary University of London
Phase
Not applicable
Overall status
Not yet recruiting
Start date
November 1, 2026
Completion date
December 1, 2029
Enrollment
44 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

medication-related osteonecrosis of the jaw